The effect of high dose of intramuscular vitamin D supplement injections on depression in patients with type 2 diabetes and vitamin D deficiency: A randomized controlled clinical trial

Aim Although antidepressants can relieve the symptoms of depression in patients with type-2 diabetes mellitus, the effect of vitamin D supplementation as an antidepressant remains unclear. The present study aimed to investigate the impact of intramuscular vitamin D supplement injections on depression and anthropometric indices in patients with type 2 diabetes who had vitamin D deficiency. Methods In this randomized controlled clinical trial, 50 patients with type 2 diabetes mellitus who had vitamin D deficiency were randomly divided into two groups of 25 participants. The experimental group received 200,000 IU of vitamin D injection at week 0 and week 4 of the study. Anthropometric indices, serum 25-hydroxyvitamin D [25(OH)D] concentrations and Beck depression test were evaluated at the beginning and after 8 weeks. Results There were no significant differences in the baseline measures of 25(OH)D concentrations between the experimental and the non-experimental groups (P = 0.78). No significant correlation was observed between the depression score and serum 25(OH)D concentrations (r = -0.008, P = 0.95). After two months, serum 25(OH)D concentrations significantly increased in the experimental group compared with the non-experimental group (p < 0.001). The mean measures of weight, fat level, waist to hip circumference ratio and the mean depression score were not significant in the two groups after the intervention. Conclusions The intramuscular vitamin D supplement injections increased serum 25(OH)D concentrations in patients with type 2 diabetes mellitus who had vitamin D deficiency, while it had no significant effect on the depression status.